- known prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- known prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply